| Ytd | -20.60% | |
| 1y | -31.00% |
| Open | 1.60 | Prev Close | 1.60 | Low | 1.55 | High | 1.63 | Mkt Cap | 420.51M |
| Vol | 685.06K | Avg Vol | 1.39M | EPS | -1.09 | P/E | N/A | Forward P/E | -3.08 |
| Beta | 2.04 | Short Ratio | 2.48 | Inst. Own | 77.47% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-07 | 50-d Avg | 1.59 | 200-d Avg | 1.54 | 1yr Est | 10.45 |
LONDON & GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL
LONDON and GAITHERSBURG, Md., June 25, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AU